Population‐based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test
Authors:
Open Access
- 15 December 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 124 (5) , 1097-1102
Abstract
Approximately 1–2% of colorectal cancers (CRC) arise because of germline mutations in DNA mismatch repair genes, referred to as Lynch syndrome. These tumours show microsatellite instability (MSI) and loss of expression of mismatch repair proteins. Pre‐symptomatic identification of mutation carriers has been demonstrated to improve survival; however, there is concern that many are not being identified using current practices. We evaluated population‐based MSI screening of CRC in young patients as a means of ascertaining mutation carriers. CRC diagnosed in patients aged BRAF oncogene. Loss of MLH1, MSH2, MSH6 and PMS2 protein expression was evaluated in MSI+ tumours by immunohistochemistry. MSI+ tumours were found in 105/1,344 (7.8%) patients, of which 7 were excluded as possible Lynch syndrome because of BRAF mutation. Of the 98 “red flag” cases that were followed up, 25 were already known as mutation carriers or members of mutation carrier families. Germline test results were obtained for 35 patients and revealed that 22 showed no apparent mutation, 11 showed likely pathogenic mutations and 2 had unclassified variants. The proportion of MSI+ cases in different age groups that were estimated to be mutation carriers was 89% (<30 years), 83% (30–39), 68% (40–49) and 17% (50–59). We recommend MSI as the initial test for population‐based screening of Lynch syndrome in younger CRC patients, regardless of family history.Keywords
This publication has 31 references indexed in Scilit:
- Heterogeneous Staining for Mismatch Repair Proteins during Population-Based Prescreening for Hereditary Nonpolyposis Colorectal CancerThe Journal of Molecular Diagnostics, 2007
- It Is Time to Get Serious About Diagnosing Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer With Defective DNA Mismatch Repair) in the General PopulationGastroenterology, 2005
- BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testingJournal of Medical Genetics, 2004
- Current clinical selection strategies for identification of hereditary non‐polyposis colorectal cancer families are inadequate: a meta‐analysisClinical Genetics, 2004
- BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal CancerClinical Cancer Research, 2004
- Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC‐like families: Problems in diagnosis, surveillance, and managementCancer, 2003
- Hereditary Colorectal CancerNew England Journal of Medicine, 2003
- Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the DiseaseNew England Journal of Medicine, 1998
- A cost-effectiveness analysis of colorectal screening for hereditary nonpolyposis colorectal carcinoma gene carriersCancer, 1998
- Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesisNature, 1993